Antibodies Market by Product (Primary Antibodies, Secondary Antibodies, Serum Protein Antibodies, Epitope Tag Antibodies, Isotope Control Antibodies, and Others), by Application (Rheumatoid Arthritis, Multiple Sclerosis, Oncology, Crohn’s Disease, Infectious Diseases, and Others), by End User (Contract Research Organization, Academic and Research Institutes, Pharmaceutical and Biopharmaceutical Companies, Forensic Science Laboratories, Diagnostic Centers, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019– 2027

  • To Be Published : Nov 2019 |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Antibodies, are also known as an immunoglobulins, are large Y-shaped proteins that are produced by specialized white blood cells (B-lymphocytes). Major function of antibodies is to neutralize the pathogens such as pathogenic bacteria and viruses. Immunoglobulins are classified into five classes on the basis of their constant region, namely IgG, IgM, IgD, IgA, and IgE. Antibodies market covers the product such as monoclonal antibodies and polyclonal antibodies, and has applications in treatment of, oncology, immunology, and infectious diseases.

Antibodies Market Drivers

Increasing research and development activities for treatment of diseases such as cancer, Ebola, rheumatoid arthritis, multiple sclerosis is expected to propel the growth of the market. For instance, in May 2018, National Institute of Health (NIH) initiated clinical phase I study using single monoclonal antibody (mAb114) for the treatment of Ebola at Bethesda, Maryland, U.S. The study is expected to be completed in November 2024.

Furthermore, in May 2019, the National Cancer Institute developed an antibody, drug conjugate (lorvotuzumab mertansine), for treatment of neuroblastoma in children. This antibody-drug conjugates (lorvotuzumab mertansine) kills the neuroblastoma cells in the children.

Antibodies Market Restraints

Increasing challenges in production of antibodies is expected to hamper the antibodies market growth. For instance, in May 2017, according to the National Center for Biotechnology Information (NCBI), high cost of resources and animal use is a major challenge for production of antibodies, therefore, limited resources and animals are used in the antibodies production process.

Antibodies Market – Regional Analysis

On the basis of region, the global antibodies market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the antibodies market owing to increasing collaboration and acquisition activities by the market players in the region. For instance, in January 2019, Integral Molecular, Inc (headquartered in Philadelphia, U.S.) collaborated with Ono Pharmaceutical Co., LTD (headquartered in Osaka, Japan). Integral Molecular is a leader in the discovery of monoclonal antibodies. As part of the collaboration, Integral Molecular provided a platform to Ono pharmaceuticals for discovery of  monoclonal antibodies against an undisclosed target.

Furthermore, Asia Pacific is expected to witness significant growth in the antibodies market over the forecast period. Increasing research and development activities are expected to propel growth of the antibodies market in the region. According to GaBI (Generics and Biosimilar Initiative) report, in January 2019, Innovent Company received an approval for two monoclonal antibodies (IB 305 and HLX22) from China’s Food and Drug administration. These monoclonal antibodies are used for treatment of diseases such as lung cancer, breast cancer, glioblastoma, kidney cancer, and ovarian cancer.

Key players operating in the global antibodies market include BioLegend, BETHYL, BIORAD, Enzo, Abnova, Gene Tex, ORIGENE, ROCKLAND antibiotics and assays, Invitrogen by Thermo Fisher Scientific, and ImmuQuest.

Antibodies Market –Taxonomy

   On the basis of product, the global antibodies market is segmented into:

  • Primary Antibodies
  • Secondary Antibodies (Assays Antibodies)
  • Serum protein Antibodies
  • Epitope Tag Antibodies
  • Isotope Control Antibodies
  • Others

      On the basis of application, the global antibodies market is segmented into:

  • Rheumatoid arthritis
  • Multiple sclerosis
  • Oncology
  • Crohn’s disease
  • Infectious Diseases
  • Others

    On the basis of end user, the global antibodies market is segmented into:

  • Contract Research Organization (CRO)
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnological Companies
  • Forensic Science Laboratories
  • Diagnostic Centers
  • Others

       On the basis of region, global antibodies market is segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

 

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.